Beyond labels: A review of the application of quantum dots as integrated components of assays, bioprobes, and biosensors utilizing optical transduction

A comprehensive review of the development of assays, bioprobes, and biosensors using quantum dots (QDs) as integrated components is presented. In contrast to a QD that is selectively introduced as a label, an integrated QD is one that is present in a system throughout a bioanalysis, and simultaneously has a role in transduction and as a scaffold for biorecognition. Through a diverse array of coatings and bioconjugation strategies, it is possible to use QDs as a scaffold for biorecognition events. The modulation of QD luminescence provides the opportunity for the transduction of these events via fluorescence resonance energy transfer (FRET), bioluminescence resonance energy transfer (BRET), charge transfer quenching, and electrochemiluminescence (ECL). An overview of the basic concepts and principles underlying the use of QDs with each of these transduction methods is provided, along with many examples of their application in biological sensing. The latter include: the detection of small molecules using enzyme-linked methods, or using aptamers as affinity probes; the detection of proteins via immunoassays or aptamers; nucleic acid hybridization assays; and assays for protease or nuclease activity. Strategies for multiplexed detection are highlighted among these examples. Although the majority of developments to date have been in vitro, QD-based methods for ex vivo biological sensing are emerging. Some special attention is given to the development of solid-phase assays, which offer certain advantages over their solution-phase counterparts.     

Sample cleanup-free determination of mycophenolic acid and its glucuronide in serum and plasma using the novel technology of ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry

Mycophenolic acid (MPA) is an immunosuppressant drug which powerfully inhibits lymphocyte proliferation. Since the early 1990s it has been used to prevent rejection in organ transplantation. The requirement of therapeutic drug monitoring shown in previous studies raises the necessity of acquiring accurate and sensitive methods to measure MPA and its major metabolite mycophenolic acid glucuronide (MPAG).The authors developed a sample cleanup-free, rapid, and highly specific method for simultaneous measurement of MPA and MPAG in human plasma and serum using the novel technology of ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry. MPA- and MPAG-determinations were performed during a 2.0-min run time. Multiple calibration curves for the analysis of MPA and MPAG exhibited consistent linearity and reproducibility in the range of 0.05-100 (r > 0.999) mg L⁻¹ and 4-4000 mg L⁻¹ (r > 0.999), respectively. Limits of Detection were 0.014 mg L⁻¹ for MPA and 1.85 mg L⁻¹ for MPAG. Lower Limits of Quantification were 0.05 mg L⁻¹ for MPA and 2.30 mg L⁻¹ for MPAG. Interassay imprecision was <10% for both substances. Mean recovery was 103.6% (range 78.1-129.7%) for MPA and 111.1% (range 73.0-139.6%) for MPAG. Agreement was good for MPA and MPAG between the presented method and a validated HPLC-MS/MS method. The Passing-Bablok regression line for MPA and MPAG was HPLC-MS/MS = 1.14 UPLC-MS/MS—0.14 [mg L⁻¹], r = 0.96, and HPLC-MS/MS = 0.77 UPLC-MS/MS + 0.50 [mg L⁻¹], r = 0.97, respectively. This sample cleanup-free and robust LC-MS/MS assay facilitates the rapid, accurate and simultaneous determination of MPA and MPAG in human body fluids.     

Self‐Assembled Micelles Based on PEG‐Polypeptide Hybrid Copolymers for Drug Delivery

A series of amphiphilic poly(L ‐leucine)‐block‐poly(ethylene glycol)‐block‐poly(L ‐leucine) (PLL‐PEG‐PLL) hybrid triblock copolymers have been synthesized. All the blocks in this system have good biocompatibility and low toxicity. The PLL‐PEG‐PLL copolymers could self‐assemble into micelles with PLL blocks as the hydrophobic core and PEG blocks as the hydrophilic shell, which were characterized by FT‐IR, ¹H NMR, and transmission electron microscopy analysis. The critical micellar concentration of the copolymer was 95.0 mg · L⁻¹. The circular dichroism spectrum shows that the PLL segments adopt a unique α‐helical conformation, which is found to play an important role in controlling the drug release rate. The drug release could be effectively sustained by encapsulation in the micelles. The copolymers may have potential applications in drug delivery.

     

Toward Tailor‐Made Biocide Materials Based on Poly(propylene)/Copper Nanoparticles

A set of poly(propylene) composites containing different amounts of copper nanoparticles (CNP) were prepared by the melt mixed method and their antimicrobial behavior was quantitatively studied. The time needed to reduce the bacteria to 50% dropped to half with only 1 v/v % of CNP, compared to the polymer without CNP. After 4 h, this composite killed more than 99.9% of the bacteria. The biocide kinetics can be controlled by the nanofiller content; composites with CNP concentrations higher than 10 v/v % eliminated 99% of the bacteria in less than 2 h. X‐ray photoelectron spectroscopy did not detect CNP at the surface, therefore the biocide behavior was attributed to copper in the bulk of the composite.

     

PEO‐Covered Nanoparticles by Emulsion Inversion Point (EIP) Method

This study reports the first PEO‐coated polymer nanoparticles synthesis by miniemulsion polymerization of nano‐emulsions prepared by the low‐energy emulsification method called EIP. The surfactant used was Brij 98, a PEO based non ionic commercial surfactant. The partial phase diagram of the system water/Brij 98/styrene was first determined. The Emulsion Inversion Point technique was then used on the water/Brij 98/styrene system to the formation of styrene‐in‐water nano‐emulsions. After miniemulsion polymerization, particle sizes as low as 36 nm were obtained. To the best of our knowledge, this method had not been used for polymerizable system up to now.

     

Au/CdS Hybrid Nanoparticles in Block Copolymer Micellar Shells

A polystyrene‐block‐poly(2‐vinylpyridine) (PS‐b‐P2VP) micellar structure with a P2VP core containing 5 nm CdS nanoparticles (NPs) and a PS shell formed in toluene that is a good solvent for PS block undergoes the core‐shell inversion by excess addition of methanol that is a good solvent for P2VP block. It leads to the formation of micellar shell‐embedded CdS NPs in the methanol major phase. The spontaneous crystalline growth of Au NPs on the CdS surfaces positioned at micellar shells without a further reduction process is newly demonstrated. The nanostructure of Au/CdS/PS‐b‐P2VP hybrid NPs is confirmed by transmission electron microscopy, energy‐dispersive X‐ray, and UV‐Vis absorption.

     

Application of Chitosan-Based Biomaterials for Blood Vessel Regeneration

Summary: Vascular diseases are the leading cause of morbidity and mortality in the western world. Autologous vessels remain the standard for coronary grafting and peripheral bypass surgery; however, their availability in patients can be limited. Therapeutic angiogenesis using growth factors, genes, or progenitor cells has been given considerable scientific attention over the last decade, but has not yet provided a definitive clinical benefit. Biomaterials could be developed to protect protein, DNA and cells against hostile conditions. Chitosan, a natural polymer of glucosamine and N-acetyl glucosamine, has been widely studied in tissue engineering due to its biocompatibility, biodegradability, and muco-adhesive and antimicrobial properties. Notably, the application of chitosan has been gaining attention in the vascular field due to its structural similarity to glycosaminoglycans, which are components of a tissue's extracellular matrix. In this review, chitosan-based materials, and their use in tissue engineered blood vessels, and as protein, gene and cell vectors for angiogenic therapy are discussed.     

Preparation,Characterization and Application of Modified Surfaces with 3,5-Bis(3,5-dinitrobenzoyl-amino) benzoic acid

Summary: The spontaneous adsorption of the dendron 3,5-Bis (3,5-dinitrobenzoylamino) benzoic acid (D-NO₂) onto gold and carbon electrodes produced conductive surfaces with electroactive chemical functions. A comparative electrochemical behavior of both electrodes after dendron immobilization led us to conclude that the self-assembly of D-NO₂ on carbon is faster and stronger. Considering this advantage, the surface of magnetic maghemite nanoparticles (MNPs) was modified using D-NO₂. Firstly, MNPs were modified with APS as silane coupling agent and afterwards, D-NO₂ was covalently attached to the surface, achieving nitro-functionalized MNPs. Subsequently, the immobilization of these modified MNPs onto glassy carbon surfaces was explored to generate a novel platform promising for biosensors development.     

Preparation,Characterization and Controlled Release Investigation of Biocompatible pH-Sensitive PVA/PAA Hydrogels

In the present research hydrogel films based on polyvinyl alcohol (PVA) and polyacrylic acid (PAA) blend, with various crosslink densities, have been prepared through different thermal treatment. The results of FTIR and DSC confirmed quality and quantity of conclusion on miscibility of PVA/PAA blends, respectively. Besides, biocompatibility of the samples has been proved in cytotoxicity tests using L929 cells, according to ISO10993–5. Water uptake of the hydrogel blends is measured. pH sensitivity properties of blends are studied with and without boiling in NaOH solutions where the effect of swelling in water before boiling has also been investigated. Preswellings in water and NaOH concentration have been found to be mainly effective on pH sensitivity of PVA/PAA blends. Biocompatibility and pH sensitivity behavior make these hydrogels appropriate candidates to orally deliver drugs such as insulin and peptides that can be released in basic pH of intestine. The stability of these films in acidic solutions and its expansion and also the consequent release of drugs in basic solutions have been studied by using Teofilin as a model drug by UV-spectrophotometeric measurements.     

Spectrofluorimetric determination of fexofenadine hydrochloride in pharmaceutical preparation using silver nanoparticles

A novel sensitive fluorimetric method was investigated for the assay of fexofenadine hydrochloride (FEX) using silver nanoparticles (NPs) as a fluorescence probe. The NPs, which were prepared by chemical reduction of silver nitrate with sodium borohydride (reducing agent) in aqueous solution (without organic stabilizers) were water soluble, stable and had narrow emission band. The addition of drug to NPs solution caused considerable quenching of the emission band of silver NPs, which was likely due to the complexation of the drug to silver NPs. Under the optimum conditions, the quenched fluorescence (FL) intensity was linear with the concentration of FEX in the range of 1 × 10^?7 to 2.5 × 10^?5 mol L^?1 (0.9985) with a detection limit of 1.2 × 10^?8 mol L^?1. The quenching mechanism of the studied drug on the emission band of silver NPs was explained by Stern–Volmer law. The developed method was applied to FEX determination in a pharmaceutical formulation (allegra tablets) and biological fluids (human serum and urine).